Testing

From: 'Chronic Fatigue Syndrome, A Roadmap for Testing and Treatment' <a href="https://sites.google.com/site/cfstestingandtreatmentroadmap/home">https://sites.google.com/site/cfstestingandtreatmentroadmap/home</a>

HHV-6 antibodies. Dr A Martin Lerner says that when tested using the <a href="https://www.labcorp.com/test-menu/28471/human-herpesvirus-6-hhv-6-igm" target="blank" rel="nofollow" >LabCorp HHV-6 IgM</a> test and the <a href="https://www.labcorp.com/test-menu/28461/human-herpesvirus-6-hhv-6-antibodies-igg" target="blank" rel="nofollow" >LabCorp HHV-6 IgG</a> test, antibody titers of 1:160 or higher are indicative of an active HHV-6 infection.<a href="http://www.treatmentcenterforcfs.com/documents/MECFSTreatmentResourceGuideforPractitioners.pdf" rel="nofollow" target="blank" >1</a> <a href="https://www.dovepress.com/subset-directed-antiviral-treatment-of-142-herpesvirus-patients-with-c-peer-reviewed-article-VAAT" target="blank" rel="nofollow" >2</a>

Alternatively, Professor Jose Montoya considers that when tested using the <a href="http://www.questdiagnostics.com/testcenter/BUOrderInfo.action?tc=101426&labCode=QSO" target="blank" rel="nofollow" >Quest HHV-6 IgG IFA test</a>, an HHV-6 IgG antibody titer of 1:320 or higher is indicative of an active infection.<a href="http://www.ncbi.nlm.nih.gov/pubmed/23080504" rel="nofollow" target="blank" >1</a>

Further info:

<a href="http://hhv-6foundation.org/patients/hhv-6-testing-for-patients" rel="nofollow" target="blank" >HHV-6 Foundation: Viral Testing</a> <a href="http://www.hhv-6foundation.org/coming-soon" rel="nofollow" target="blank" > </a>